Provided that there will be no change to the manufacturing process and that there is no change to the specifications of the device, “moving manufacturing steps from Biomet UK to Biomet Spain” will qualify as an Administrative Change under category 1A Change in manufacturing facility with no change to the manufacturing process under GN-21 Guidance on Change Notification.
If there is changes in the manufacturing steps, please provide more information and details so that I can make enquiry with HSA for further clarification. HSA will not be able to understand your question base on your spreasheet and give advice as the chart is too brief.